SPON2 and glomerular disorder: The large induction of mindin expression in the diseased GBM and its presence in the majority of urine samples from FVB/N Cd151−/− mice suggests that this protein could have some potential use as a biomarker across a range of glomerular diseases associated with ultrastructural GBM damage.